for the period ended 30 April 2012

   2          CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS 

Management make critical accounting estimates and judgements concerning the future. The resulting accounting estimates will, by definition, seldom equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the financial period are outlined below:

   (a)        Fair value of derivative financial instruments 

The Company holds investments which are tailored to meet the Company's respective needs for each cell. As the investments are not traded in an active market, the fair value of such instruments is determined by using valuation techniques. The fair value is calculated weekly and as at each month end by the Counterparty. As at the reporting date, an independent check of the valuations of the investments is performed by Future Value Consultants Limited (the "Calculation Agent"), an independent third party. The Calculation Agent uses a variety of methods and makes assumptions that are based on market conditions existing at the reporting date. Valuation techniques used include the use of comparable recent arm's length transactions (where available), discounted cash flow analysis, option pricing models and other valuation techniques commonly used by market participants. These techniques are periodically reviewed by experienced personnel at the Calculation Agent.

Models use observable data, to the extent practicable. However, areas such as credit risk (both own and counterparty), volatilities, capital risk and correlations require management to make estimates. Changes in assumptions about these factors could affect the reported fair value of financial instruments.

Harewood Structured Investment PCC Limited (the "Company")

Notes to the Financial Statements (continued)

for the period ended 30 April 2012

   3          NET ASSETS ATTRIBUTABLE TO HOLDERS OF PREFERENCE SHARES 
 
                                                  Period 
                                                      to         Year to 
                                                  30 Apr 
                                                    2012     31 Oct 2011 
                                                   Total           Total 
                                                     GBP             GBP 
 
 Opening portfolio cost                      725,661,033     789,581,018 
 Opening unrealised loss on valuation      (125,369,115)    (46,362,181) 
 Opening exchange gains on currency 
  balances                                     6,569,892       6,349,870 
 
 Opening valuation                           606,861,780     749,568,707 
 
 Proceeds of sales of financial assets     (134,953,399)    (74,385,318) 
 Unrealised gain / (loss) for the 
  period / year                               51,460,702     (79,006,934 
 Realised (loss) / gains on investments     (66,294,290)      10,465,333 
 Exchange (losses) / gains on currency 
  balances                                     (967,114)         219,992 
 
 Closing valuation                           456,107,679     606,861,780 
                                          ==============  ============== 
 
 Closing portfolio cost                      524,413,344     725,661,033 
 Closing unrealised loss                    (73,908,413)   (125,369,115) 
 Closing exchange gains on currency 
  balances                                     5,602,748       6,569,862 
 
 Closing valuation                           456,107,679     606,861,780 
                                          ==============  ============== 
 

IFRS 7 requires fair value measurements to be disclosed by the source of inputs, using the following three-level hierarchy:

* Quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1)

* Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (as prices) or indirectly (derived from prices) (Level 2).

* Inputs for the asset or liability that are not based on observable market data (unobservable inputs) (Level 3).

The financial assets held by the Company have been classified as Level 2. This is in accordance with the fair value hierarchy.

There have been no transfers between Level 2 and Level 3 of the fair value hierarchy during the period under review.

Harewood Structured Investment PCC Limited (the "Company")

Notes to the Financial Statements (continued)

for the period ended 30 April 2012

   4          SHARE CAPITAL 
 
 Authorised                                SHARES   GBP 
 Preference shares of no par value 
  each                                  Unlimited     - 
 Ordinary shares of no par value each           2     - 
                                       ----------  ---- 
                                                2     - 
                                       ==========  ==== 
 
 
                          Shares issued 
 Allotted, called-up           as at                                                  Shares issued 
  and fully paid            1 November          Preference            Preference      as at 30 April 
  Preference Shares            2011           Shares Redeemed        Shares Issued         2012 
 
 Cell Agribus                            -                  -                    -                 - 
 Cell EGAA                               -                  -                    -                 - 
 Cell FTSE S                             -                  -                    -                 - 
 Cell UK HI                    141,613,549      (141,613,549)   *                -                 - 
 Cell EBM (2)                   32,506,140       (32,506,140)   *                -                 - 
 Cell ES                        25,000,000       (25,000,000)   *                -                 - 
 Cell Abs Pro                   76,748,923                  -                    -        76,748,923 
 Cell US HI A                   92,469,987                  -                    -        92,469,987 
 Cell US HI B                   58,337,229                  -                    -        58,337,229 
 Cell Agrinvest                 47,225,896                  -                    -        47,225,896 
 Cell EPR                       30,125,000                  -                    -        30,125,000 
 Cell EBM (3)                   49,587,600                  -                    -        49,587,600 
 Cell COMAC                     25,526,009                  -                    -        25,526,009 
 Cell USEI A                    48,500,080                  -                    -        48,500,080 
 Cell USEI B                    45,079,125                  -                    -        45,079,125 
 Cell UK EI                     49,015,722                  -                    -        49,015,722 
 Cell EI                        39,999,346                  -                    -        39,999,346 
 
 Ordinary Shares                         2                  -                    -                 2 
                       -------------------  -----------------      ---------------  ---------------- 
 
 TOTAL                         761,734,608      (199,119,689)                    -       562,614,919 
                       ===================  =================      ===============  ================ 
 

*See Note 8

Harewood Structured Investment PCC Limited (the "Company")

Notes to the Financial Statements (continued)

for the period ended 30 April 2012

   4          SHARE CAPITAL (continued) 
 
                        Shares issued 
 Allotted, called-up        as at                                             Shares issued 
  and fully paid          1 November       Preference        Preference      as at 31 October 
  Preference Shares          2010        Shares Redeemed    Shares Issued          2011 
 
 Cell Agribus                  72,500           (72,500)                -                   - 
 Cell EGAA                 13,500,255       (13,500,255)                -                   - 
 Cell FTSE S               40,501,195       (40,501,195)                -                   - 
 Cell UK HI               141,613,549                  -                -         141,613,549 
 Cell EBM (2)              32,506,140                  -                -          32,506,140 
 Cell ES                   25,000,000                  -                -          25,000,000 
 Cell Abs Pro              76,748,923                  -                -          76,748,923 
 Cell US HI A              92,469,987                  -                -          92,469,987 
 Cell US HI B              58,337,229                  -                -          58,337,229 
 Cell Agrinvest            47,225,896                  -                -          47,225,896 
 Cell EPR                  30,125,000                  -                -          30,125,000 
 Cell EBM (3)              49,587,600                  -                -          49,587,600 
 Cell COMAC                25,526,009                  -                -          25,526,009 
 Cell USEI A               48,500,080                  -                -          48,500,080 
 Cell USEI B               45,079,125                  -                -          45,079,125 
 Cell UK EI                49,015,722                  -                -          49,015,722 
 Cell EI                   39,999,346                  -                -          39,999,346 
                                                                        - 
 Ordinary Shares                    2                  -                -                   2 
                       --------------  -----------------  ---------------  ------------------ 
 
 TOTAL                    815,808,558       (54,073,950)                -         761,734,608 
                       ==============  =================  ===============  ================== 
 
Grafico Azioni UK Enhanced In (LSE:UKE)
Storico
Da Apr 2024 a Mag 2024 Clicca qui per i Grafici di UK Enhanced In
Grafico Azioni UK Enhanced In (LSE:UKE)
Storico
Da Mag 2023 a Mag 2024 Clicca qui per i Grafici di UK Enhanced In